ADENUBEX (Pharmacor Pty Ltd)
Product name
ADENUBEX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
152 (255 working days)
Active ingredients
febuxostat hemihydrate
Registration type
New generic medicine
Indication
Treatment of chronic symptomatic hyperuricaemia in conditions where urate deposition has already occurred (gouty arthritis and/or tophus formation) in adults with gout.